Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ovarian Neoplasms

Free Subscription Articles published in Cancer Chemother Pharmacol Retrieve available abstracts of 22 articles: HTML format Text format

Single Articles

February 2010
1. KUROKAWA T , He G, Siddik ZH
   Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner.
   Cancer Chemother Pharmacol. 2010;65:427-36.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
2. SEHOULI J , Camara O, Mahner S, Bauknecht T, et al
   A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.
   Cancer Chemother Pharmacol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
3. YUAN Z , Yan F, Wang YS, Liu HY, et al
   PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
   Cancer Chemother Pharmacol. 2009;65:13-25.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
4. TUMMALA R , Wolle D, Barwe SP, Sampson VB, et al
   Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.
   Cancer Chemother Pharmacol. 2009;64:1187-94.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
5. FERRANDINA G , Mey V, Nannizzi S, Ricciardi S, et al
   Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.
   Cancer Chemother Pharmacol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   April 2009
6. DEL BENE F , Germani M, De Nicolao G, Magni P, et al
   A model-based approach to the in vitro evaluation of anticancer activity.
   Cancer Chemother Pharmacol. 2009;63:827-36.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. STOEGER SM , Cowan KH
   Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines.
   Cancer Chemother Pharmacol. 2009;63:807-18.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2009
8. PISANO C , Morabito A, Sorio R, Breda E, et al
   A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.
   Cancer Chemother Pharmacol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. YADAV S , van Vlerken LE, Little SR, Amiji MM, et al
   Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.
   Cancer Chemother Pharmacol. 2009;63:711-22.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2009
10. MITAMURA T , Hosaka M, Takeda M, Watari H, et al
    Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report.
    Cancer Chemother Pharmacol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
11. SEHOULI J , Camara O, Schmidt M, Mahner S, et al
    Pegylated liposomal doxorubicin (CAELYX((R))) in patients with advanced ovarian cancer: results of a German multicenter observational study.
    Cancer Chemother Pharmacol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
12. MAENPAA J , Leminen A
    Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding study.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
13. HEIJNS JB , van der Burg ME, van Gelder T, Fieren MW, et al
    Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
    Cancer Chemother Pharmacol. 2008;62:841-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
14. LIU H , Liang SL, Kumar S, Weyman CM, et al
    Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
15. TARAN A , Ignatov A, Smith B, Costa SD, et al
    Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Text format     Related articles   
    
    
    
16. ZAMBONI WC , Strychor S, Joseph E, Parise RA, et al
    Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
    Cancer Chemother Pharmacol. 2008;62:417-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
17. BROWN DP , Chin-Sinex H, Nie B, Mendonca MS, et al
    Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
18. DUAN Z , Ames RY, Ryan M, Hornicek FJ, et al
    CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
19. CAMCI C , Sevinc A, Aslan Y, Kalender ME, et al
    Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. CHEN J , Adikari M, Pallai R, Parekh HK, et al
    Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
    Cancer Chemother Pharmacol. 2008;61:979-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
21. JI C , Cao C, Lu S, Kivlin R, et al
    Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. BANERJI U , Sain N, Sharp SY, Valenti M, et al
    An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: